Preliminary results of a phase 2 clinical trial of Genz-112638 in patients with type I Gaucher disease

被引：0
|
作者：
Lukina, E. [1 ]
Watman, N. [2 ]
Arreguin, E. A.
Banikazemi, M. [3 ]
Iastrebner, M. [4 ]
Rosenbaum, H. [5 ]
Zimran, A. [6 ]
O'Brien, F.
Smith, S. E.
Puga, A. C.
Peterschmitt, J.
机构：
[1] Russian Acad Med Sci, Hematol Res Ctr, Moscow, Russia
[2] Hosp Ramos Mejia, Buenos Aires, DF, Argentina
[3] NYU, New York, NY USA
[4] Inst Argentino Diagnost & Tratamiento, Buenos Aires, DF, Argentina
[5] Ramban Med Ctr, Haifa, Israel
[6] Shaare Zedek Med Ctr, Jerusalem, Israel
来源：
JOURNAL OF INHERITED METABOLIC DISEASE | 2008年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
450P
引用
收藏
页码：114 / 114
页数：1
相关论文
共 50 条
  • [21] Bone quality in patients with type 1 Gaucher disease: Validation and preliminary results with microindentation
    Perez-Lopez, Jordi
    Herrera, Sabina
    Diez-Perez, Adolfo
    Ceberio, Leticia
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (02) : S94 - S94
  • [22] Phase I/II study of glucocerebrosidase replacement therapy in patients with type I Gaucher disease
    Zimran, A
    Elstein, D
    Loveday, K
    Aliski, W
    Fratazzi, C
    ACTA PAEDIATRICA, 2006, 95 : 143 - 143
  • [23] Untreated patients with type 1 Gaucher disease: Who are they? Preliminary results from the Gaucher non-treated study
    Serratrice, Christine
    Stirnemann, Jerome
    Berrahal, Amina
    Bengherbia, Monia
    Belmatoug, Nadia
    Camou, Fabrice
    Berger, Marc
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S128 - S129
  • [24] The clinical management of type 2 Gaucher disease
    Weiss, Karin
    Gonzalez, Ashley N.
    Lopez, Grisel
    Pedoeim, Leah
    Groden, Catherine
    Sidransky, Ellen
    MOLECULAR GENETICS AND METABOLISM, 2015, 114 (02) : 110 - 122
  • [25] TRIHEPTANOIN FOR PATIENTS WITH GLYCOGEN STORAGE DISEASE TYPE I (GSDI): PILOT CLINICAL TRIAL RESULTS
    El-Gharbawy, Areeg
    Cao, Joseph
    Pendyal, Surekha
    Li, Cindy
    Workman, Lauren
    Mavis, Alisha
    Stiles, Ashlee
    Young, Sarah
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (03) : 46 - 46
  • [26] A phase 2 clinical trial of the pharmacological chaperone AT2101 for the treatment of Gaucher disease
    Weinreb, N.
    Schneider, E.
    Dinh, Q.
    Duke, C.
    Insinga, A. F.
    Scott, K.
    Do, H.
    Wustman, B.
    Palling, D.
    Lockhart, D. J.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 : 108 - 108
  • [27] Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results
    Mistry, Pramod K.
    Lukina, Elena
    Ben Turkia, Hadhami
    Shankar, Suma P.
    Feldman, Hagit Baris
    Ghosn, Marwan
    Mehta, Atul
    Packman, Seymour
    Lau, Heather
    Petakov, Milan
    Assouline, Sarit
    Balwani, Manisha
    Danda, Sumita
    Hadjiev, Evgueniy
    Ortega, Andres
    Foster, Meredith C.
    Gaemers, Sebastiaan J. M.
    Peterschmitt, M. Judith
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (09) : 1156 - 1165
  • [28] Outcomes after 8 years of eliglustat therapy for Gaucher disease type 1: Final results from the Phase 2 trial
    Lukina, Elena
    Watman, Nora
    Dragosky, Marta
    Lau, Heather
    Avila Arreguin, Elsa
    Rosenbaum, Hanna
    Zimran, Ari
    Foster, Meredith C.
    Gaemers, Sebastiaan J. M.
    Peterschmitt, M. Judith
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (01) : 29 - 38
  • [29] Eliglustat, an investigational oral therapy for Gaucher disease type 1: Phase 2 trial results after 4 years of treatment
    Lukina, Elena
    Watman, Nora
    Dragosky, Marta
    Pastores, Gregory M.
    Arreguin, Elsa Avila
    Rosenbaum, Hanna
    Zimran, Ari
    Angell, Jennifer
    Ross, Leorah
    Puga, Ana Cristina
    Peterschmitt, Judith M.
    BLOOD CELLS MOLECULES AND DISEASES, 2014, 53 (04) : 274 - 276
  • [30] PRELIMINARY-RESULTS OF A PHASE-I TRIAL
    BRETEAU, N
    SABATTIER, R
    FAVRE, A
    DESTEMBERT, B
    BULLETIN DU CANCER, 1983, 70 (03) : 229 - 229
12345